NCT07223047
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07223047
Title A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Bristol-Myers Squibb
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP | CAN

Facility Status City State Zip Country Details
Local Institution - 0009 NOT_YET_RECRUITING Baltimore Maryland 21205 United States Details
NEXT Oncology RECRUITING San Antonio Texas 78229 United States Details
Local Institution - 0007 NOT_YET_RECRUITING Salt Lake City Utah 84124 United States Details
Local Institution - 0011 NOT_YET_RECRUITING Fairfax Virginia 22031 United States Details
Local Institution - 0002 NOT_YET_RECRUITING Vancouver British Columbia V5Z 4E6 Canada Details
Local Institution - 0010 NOT_YET_RECRUITING Toronto Ontario M5G 2M9 Canada Details
Local Institution - 0006 NOT_YET_RECRUITING Badalona Barcelona [Barcelona] 08916 Spain Details
Local Institution - 0008 NOT_YET_RECRUITING Hortaleza Madrid 28050 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field